Fountainheadinvesting

Fountainhead Investing

Objective Analysis: Research On High Quality Companies With Sustainable Moats
Tech Focused: 60% Allocated To AI, Semiconductors, Technology

5 Star Tech Analyst Focused On Excellent Companies With Sustainable Moats

Pharmaceuticals Trade Alert

Trade Alert: Acquired Eli Lilly (LLY) at $732 with Promising Growth Ahead

Post author By Fountainhead
Post date 04/22/2024
No Comments on Trade Alert: Acquired Eli Lilly (LLY) at $732 with Promising Growth Ahead

source

Bought Eli Lilly (LLY)$732

My initial target was $720-725 when I first analyzed the company around $770. Eli should have at least 3-4 years of growth on obesity blockbusters.

Tags Eli Lilly, Growth Potential, Investment Strategy, LLY, Long-Term Investment, Obesity Treatments, Pharmaceutical Industry, Trade Alert

Leave a Reply Cancel reply